Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment

Australia

• National Breast and Ovarian Cancer Centre
  • Recommendations for endocrine therapy treatment of hormone receptor-positive advanced breast cancer [2009]

• National Health and Medical Research Council
  • Clinical practice guidelines for the management and support of younger women with breast cancer [2003]
  • Clinical practice guidelines for the management of early breast cancer. Second edition [2001]
  • Clinical Practice Guidelines for the Management of Advanced Breast Cancer [2001]

Canada

• Cancer Care Ontario
  • The Prophylactic Use of Filgrastim in Patients with Breast Cancer [2009]
  • The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer: A Clinical Practice Guideline [2006]
  • Management of ductal carcinoma in situ of the breast: a clinical practice guideline [2006]
  • Adjuvant Systemic Therapy for Node-Negative Breast Cancer [2003]

• Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
  • Clinical practice guidelines for the care and treatment of breast cancer: 9. Follow-up after treatment for breast cancer (2005 update) [2005]
  • Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer [2004]
  • Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update) [2003]
  • Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 7. Adjuvant systemic therapy for women with node-negative breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 5. Management of ductal carcinoma in situ (DCIS) (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 10. The management of chronic pain in patients with breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected [1998]
  • Clinical practice guidelines for the care and treatment of breast cancer

Europe

• Annals of Oncology
  • Third consensus on medical treatment of metastatic breast cancer [2009]

• Central European Cooperative Oncology Group
  • Second consensus on medical treatment of metastatic breast cancer [2007]

• European Society of Mastology
  • Role of complementary and alternative medicine in the management of early breast cancer [2006]
  • Guidelines on endocrine therapy of breast cancer [2002]

International

• Annals of Oncology
  • Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 [2009]
  • Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [2005]

• Breast Health Global Initiative
  • Locally advanced breast cancer : Treatment guideline implementation with particular attention to low- and middle-income countries [2008]
  • Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation [2008]
  • Effective but cost-prohibitive drugs in breast cancer treatment : A clinician's perspective [2008]

• Cochrane Library
  • Systemic therapy for treating locoregional recurrence in women with breast cancer
  • Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
  • Specialist breast care nurses for supportive care of women with breast cancer
  • Single agent versus combination chemotherapy for metastatic breast cancer
  • Sequencing of chemotherapy and radiation therapy for early breast cancer
  • Psychological interventions for women with metastatic breast cancer
  • Platinum containing regimens for metastatic breast cancer
  • Physical therapies for reducing and controlling lymphoedema of the limbs
  • LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
  • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
  • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
  • Follow-up strategies for women treated for early breast cancer
  • Exercise for women receiving adjuvant therapy for breast cancer
  • Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
  • Benzo-pyrones for reducing and controlling lymphoedema of the limbs
  • Antitumour antibiotic containing regimens for metastatic breast cancer
  • Addition of drug/s to a chemotherapy regimen for metastatic breast cancer

• Endocrine-Related Cancer
  • Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment [2005]

• Journal of the National Cancer Institute
  • International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? [2010]
  • International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy [2009]

United Kingdom

• Health Technology Assessment
  • Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review [2008]
  • Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy [2006]

United States of America

• American College of Radiology
  • Locally Advanced Breast Cancer [2011]

• American Society of Clinical Oncology
  • American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer [2011]
  • American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer [2010]
  • American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction [2009]
  • American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting [2006]

• National Cancer Institute
  • Breast Cancer: Treatment

• National Guideline Clearinghouse
  • American Society of Clinical Oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer [2011]
  • ACR Appropriateness Criteria® locally advanced breast cancer [2011]
  • American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer [2010]
  • The prophylactic use of filgrastim in patients with breast cancer. Program in Evidence-based Care [2009]
  • Systemic therapy: endocrine therapies. In: Management of early breast cancer. New Zealand Guidelines Group [2009]
  • Systemic therapy: chemotherapy regimens. In: Management of early breast cancer. New Zealand Guidelines Group [2009]
  • Follow-up. In: Management of early breast cancer. New Zealand Guidelines Group [2009]
  • American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction [2009]
  • Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Breast Health Global Initiative [2008]

Articles in journals

• Annals Academy of Medicine Singapore
  • The feminist approach in the decision-making process for treatment of women with breast cancer [2006]

• Annals of Oncology
  • What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? [2009]
  • Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer [2009]
  • Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer [2009]
  • Effective oral chemotherapy for breast cancer: pillars of strength [2008]
  • Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies [2008]
  • A review of the use of trastuzumab (Herceptin(R)) plus vinorelbine in metastatic breast cancer [2008]
  • Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy [2006]
  • New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy [2005]
  • Neo-adjuvant therapy in breast cancer [2005]
  • An integrated approach for tailored treatment in breast cancer [2005]
  • Adjuvant treatment for early breast cancer [2005]

• Annals of Surgical Oncology
  • Metastasectomy and Surgical Resection of the Primary Tumor in Patients With Stage IV Breast Cancer [2010]

• Australian Family Physician
  • Survivorship care after breast cancer [2008]
  • Life after breast cancer [2006]
  • Breast Cancer. Guiding your patient through treatment [2006]
  • Management of early breast cancer - The current approach [2005]

• Biology of Reproduction
  • Targeting Breast and Prostate Cancers Through Their Hormone Receptors [2005]

• BMC Cancer
  • Return to work of breast cancer survivors: a systematic review of intervention studies [2009]

• Breast Cancer
  • Recent perspectives of endocrine therapy for breast cancer [2007]
  • Optimizing the antihormonal treatment and prevention of breast cancer [2007]
  • Economic evaluation of the prevention and treatment of breast cancer--present status and open issues [2007]
  • Current status of health outcome assessment of medical treatment in breast cancer [2007]
  • Current clinical trials of endocrine therapy for breast cancer [2007]

• Breast Cancer Research
  • Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents [2009]
  • Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer [2009]
  • New Diagnostics and Biological Predictors of Outcome in Early Breast Cancer [2009]
  • Are we HER-ting for innovation in neoadjuvant breast cancer trial design? [2009]
  • Molecular targeted therapies for breast cancer treatment [2008]

• Canadian Family Physician
  • Management of secondary lymphedema related to breast cancer [2010]

• Canadian Medical Association Journal
  • Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis [2006]

• Cancer
  • A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health [2009]

• Clinical Breast Cancer
  • Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? [2009]
  • Enhancing the efficacy of hormonal agents with selected targeted agents [2009]
  • A question of duration: do patients with early-stage breast cancer need more than five years of adjuvant endocrine therapy? [2009]
  • A 2009 update on the treatment of patients with hormone receptor-positive breast cancer [2009]

• Clinical Cancer Research
  • Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems [2008]
  • Skeletal Complications of Breast Cancer Therapies [2006]
  • A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer [2005]

• Clinical Journal of Oncology Nursing
  • Complementary and alternative medicine use among women with breast cancer: a systematic review [2010]

• Clinical Medicine & Research
  • NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions [2003]

• Endocrine Reviews
  • Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance [2008]

• Endocrine-Related Cancer
  • Target-based therapies in breast cancer: current status and future perspectives [2009]
  • Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy [2009]
  • Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer [2006]
  • Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk [2006]
  • Is oestrogen receptor- {beta} a predictor of endocrine therapy responsiveness in human breast cancer? [2006]
  • The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers [2005]
  • The NF{kappa}B pathway and endocrine-resistant breast cancer [2005]
  • Overview of the impact of conventional systemic therapies on breast cancer [2005]
  • Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer [2005]
  • Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience [2005]
  • Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity [2005]
  • Effects of estrogen deprivation due to breast cancer treatment [2004]

• Exercise and Sport Sciences Reviews
  • Balancing Lymphedema Risk: Exercise Versus Deconditioning for Breast Cancer Survivors [2010]

• Future Oncology
  • Emerging therapeutic targets in breast cancer bone metastasis [2010]

• Japanese Journal of Clinical Oncology
  • Targeted Therapy in Breast Cancer: Current Status and Future Directions [2010]
  • Current Trends and Controversies over Pre-operative Chemotherapy for Women with Operable Breast Cancer [2007]

• Journal of Clinical Endocrinology & Metabolism
  • To Block Estrogen’s Synthesis or Action: That Is the Question [2002]

• Journal of Experimental & Clinical Cancer Research
  • Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 [2009]

• Journal of Nuclear Medicine
  • The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions [2009]
  • Response to Therapy in Breast Cancer [2009]

• Journal of the National Cancer Institute
  • Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials [2010]
  • Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer [2008]
  • Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer [2005]
  • Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis [2005]

• Medical Journal of Australia
  • Systemic adjuvant therapies for early breast cancer: 15-year results for recurrence and survival [2005]
  • Breast cancer in Western Australia: clinical practice and clinical guidelines [2004]

• Oncologist
  • The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine [2009]
  • Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy [2009]

• Radiation Oncology
  • Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology [2010]

• Revista Latino-Americana de Enfermagem
  • Physiotherapy treatments for breast cancer-related lymphedema: a literature review [2009]

{Related topics}

• Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
  • Treatment of breast cancer : Clinical tools, medical calculators

• Guidelines
  • Breast cancer treatment: vinca alkaloids
  • Breast cancer treatment: tyrosine kinase inhibitors
  • Breast cancer treatment: taxanes
  • Breast cancer treatment: surgery, radiotherapy
  • Breast cancer treatment: monoclonal antibodies
  • Breast cancer treatment: epothilones
  • Breast cancer treatment: bisphosphonates
  • Breast cancer treatment: aromatase inhibitors
  • Breast cancer treatment: antimetabolites
  • Breast cancer treatment: antiestrogens
  • Breast cancer treatment: anthracyclines
  • Breast cancer